These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32433846)

  • 1. Difelikefalin in Hemodialysis Patients with Pruritus.
    Manenti L; Rossi GM; Fiaccadori E
    N Engl J Med; 2020 May; 382(21):2064. PubMed ID: 32433846
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis: A Randomized Clinical Trial.
    Narita I; Tsubakihara Y; Uchiyama T; Okamura S; Oya N; Takahashi N; Gejyo F;
    JAMA Netw Open; 2022 May; 5(5):e2210339. PubMed ID: 35511180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difelikefalin: A New κ-Opioid Receptor Agonist for the Treatment of Hemodialysis-Dependent Chronic Kidney Disease-Associated Pruritus.
    Fugal J; Serpa SM
    Ann Pharmacother; 2023 Apr; 57(4):480-488. PubMed ID: 35942600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
    Yosipovitch G; Awad A; Spencer RH; Munera C; Menzaghi F
    J Am Acad Dermatol; 2023 Aug; 89(2):261-268. PubMed ID: 37059302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
    Fishbane S; Jamal A; Munera C; Wen W; Menzaghi F;
    N Engl J Med; 2020 Jan; 382(3):222-232. PubMed ID: 31702883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis.
    Rastogi A; Fishbane S; Lerma E
    Expert Rev Clin Pharmacol; 2023 May; 16(5):387-400. PubMed ID: 37010031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difelikefalin in Hemodialysis Patients with Pruritus.
    Lin CH
    N Engl J Med; 2020 May; 382(21):2064-2065. PubMed ID: 32433847
    [No Abstract]   [Full Text] [Related]  

  • 8. Difelikefalin in Hemodialysis Patients with Pruritus.
    Brennan F; Davison S; Brown M
    N Engl J Med; 2020 May; 382(21):2064. PubMed ID: 32433845
    [No Abstract]   [Full Text] [Related]  

  • 9. Difelikefalin in Hemodialysis Patients with Pruritus. Reply.
    Fishbane S
    N Engl J Med; 2020 May; 382(21):2065-2066. PubMed ID: 32433848
    [No Abstract]   [Full Text] [Related]  

  • 10. An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease.
    Lipman ZM; Yosipovitch G
    Expert Opin Pharmacother; 2021 Apr; 22(5):549-555. PubMed ID: 33190563
    [No Abstract]   [Full Text] [Related]  

  • 11. Difelikefalin for pruritus associated with renal disease.
    Manenti L; Fenaroli P
    Drugs Today (Barc); 2022 Sep; 58(9):427-435. PubMed ID: 36102903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of refractory pruritus with difelikefalin in a patient on incremental hemodialysis one day a week: Is it safe and effective?
    de la Flor JC; Cruzado L; Deira J; Valga F; Sualdea B; Zamora R; Rodeles M
    Nefrologia (Engl Ed); 2024; 44(3):437-439. PubMed ID: 38890063
    [No Abstract]   [Full Text] [Related]  

  • 13. Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review.
    Wala K; Szepietowski JC
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis.
    Thokala P; Hnynn Si PE; Hernandez Alava M; Sasso A; Schaufler T; Soro M; Fotheringham J
    Pharmacoeconomics; 2023 Apr; 41(4):457-466. PubMed ID: 36735201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients.
    Fishbane S; Mathur V; Germain MJ; Shirazian S; Bhaduri S; Munera C; Spencer RH; Menzaghi F;
    Kidney Int Rep; 2020 May; 5(5):600-610. PubMed ID: 32405581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study.
    Weiner DE; Vervloet MG; Walpen S; Schaufler T; Munera C; Menzaghi F; Wen W; Bhaduri S; Germain MJ;
    Kidney Med; 2022 Oct; 4(10):100542. PubMed ID: 36185706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the physical dependence potential of difelikefalin: Randomized placebo-controlled study in patients receiving hemodialysis.
    Spencer RH; Munera C; Shram MJ; Menzaghi F
    Clin Transl Sci; 2023 Sep; 16(9):1559-1568. PubMed ID: 37128642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difelikefalin for the Treatment of Uremic Pruritus.
    Steele DJR
    N Engl J Med; 2020 Jan; 382(3):289-290. PubMed ID: 31940704
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis.
    Stark JG; Noonan PK; Spencer RH; Bhaduri S; O'Connor SJ; Menzaghi F
    Clin Pharmacokinet; 2023 Sep; 62(9):1231-1241. PubMed ID: 37369955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies.
    Topf J; Wooldridge T; McCafferty K; Schömig M; Csiky B; Zwiech R; Wen W; Bhaduri S; Munera C; Lin R; Jebara A; Cirulli J; Menzaghi F
    Kidney Med; 2022 Aug; 4(8):100512. PubMed ID: 36016762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.